Bioink Market Expected to Reach US$ 1.03 Billion by 2034 with 18.8% CAGR

In 2024, the global bioink market (バイオインク市場) is estimated at US$ 185.6 million. Forecasts project a remarkable Compound Annual Growth Rate (CAGR) of 18.8%, catapulting the demand for bioinks to reach a substantial market value of US$ 1.03 billion by 2034.

Recent years have witnessed a consistent rise in the necessity for organ replacements and tissue regeneration. Innovations in these fields are anticipated to facilitate the transformation of damaged tissues into fully functional organs or tissues through the process of 3D bioprinting. Bioinks play a pivotal role in 3D bioprinting by serving as essential components in the development of organ structures. Numerous companies are actively involved in the development of bioink products, which are tailored solutions for the 3D bioprinting of organs and tissues.

The notable expansion in tissue engineering and regenerative medicine is expected to spur the creation of artificial tissue models, revolutionizing the landscape of medicine. These advanced methodologies are poised to enable the fabrication and integration of extracellular matrix and cells. Moreover, bioprinting is set to emerge as a pivotal technology in 3D biomanufacturing, facilitating precise control over cellular structures.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9475

Key Takeaways from Market Study

The global bioink market (바이오잉크 시장) is estimated at US$ 185.6 million in 2024.
Worldwide demand for bioink is predicted to reach a market value of US$ 1.03 billion by the end of 2034.
The market is projected to advance at a prolific CAGR of 18.8% from 2024 to 2034.
North America is forecasted to account for 56.9% share of global market revenue by 2034.
Sales of bioinks in China are predicted to rise at 20% CAGR and reach US$ 26.3 million by the end of 2034.
Natural bioinks are projected to account for 71.6% of global market share by 2034.

Higher Flexibility of Extrusion-based Bioprinting

Extrusion-based bioprinting is utilized in the production of objects as per CAD (computer-aided design) data through layering. The increased popularity of extrusion-based bioprinting is due to its higher flexibility in producing various biological products such as organ modules, tissues, microfluidic devices, cells, and tissue constructs. This growing adoption of the technique in different fields like clinics, pharmaceuticals, and research is creating opportunities for various players.

Key Market Players

Merck KGaA,
CELLINK,
CollPlant Biotechnologies Ltd.,
Humabiologics,
Allevi, Inc.,
Black Drop Biodrucker Gmb,
Foldink,
UPM Biomedicals,
Axolotl Biosciences,
Manchester BIOGEL,
TheWell Bioscience Inc.,
3DPL.

Competitive Landscape:

Prominent bioink manufacturers are continuously enhancing their product offerings with advanced technologies and actively engaging in mergers and acquisitions. They are also focusing on quality control, supply chain management, and new developments to maintain a competitive edge in the market.

For example:

CollPlant introduced Collink.3DTM in November 2021, designed for 3D bioprinting applications in human organs, scaffolds, and tissues.

BICO acquired Advanced BioMatris in August 2021, a US-based company with a strong portfolio of collagen bioinks, chemically modified proteins, and other cell assays, enhancing BICO's research applications in 3D bioprinting.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=9475

Segmentation of Bioink Market (Bioink-Markt) Research

By Material:

Agarose

Alginate

Chitosan

Collagen

Fibrinogen

Gelatin

Hyaluronic Acid

Graphene

Hydroxyapatite

Cell- & Tissue-derived ECM

Poly (Ethylene Glycol) Diacrylate (PEGDA)

By Source:

Natural

Synthetic

By Printing Modality:

Extrusion-based Bioprinting

Inkjet-based Bioprinting

Laser-based Bioprinting

By Application:

Tissue Engineering & Regenerative Medicines

Tissue Transplantation

Pharmaceuticals & High-throughput Screening

By Organ:

Human Ears

Kidneys

Liver

Heart

Skin

Cartilages

Bones

Stem Cells

Blood Vessels

Cancer Research

Lungs

Muscles

By End User:

Medical Device Manufacturers

Pharmaceutical Companies

Research & Academic Institutions

Contract Research Organizations

By Region:

North America

Europe

East Asia

Latin America

Middle East & Africa

South Asia & Oceania

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.